Category : Search result: Indian pharmaceutical companies


AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion

British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.

DRI Busts Illegal Alprazolam Factory in Gujarat

In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.

JSW Steel's 2030 Vision: Challenging Tata & Jindal

JSW Steel unveils aggressive expansion strategy to become world's fifth largest steel producer by 2030, targeting massive capacity increase and challenging Tata Steel's dominance in Indian steel sector.

Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs

Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.

Kaynes Technology Q2 Profit Jumps 168%

Kaynes Technology reports explosive Q2 growth with net profit surging 168% to ₹59 crore and revenue climbing 86%, driven by strong semiconductor and electronics manufacturing demand.

Japanese Omotenashi: Lessons for Indian Companies

Discover how Japanese Omotenashi - the art of selfless hospitality showcased during Tokyo Olympics - offers valuable lessons for Indian companies seeking to enhance employee experience and customer satisfaction.

Digikore Studios PAT Jumps 117% in H1 FY26

Mumbai-based Digikore Studios reports staggering 117% YoY profit growth in H1 FY26, with revenue climbing 77% as demand for VFX and animation services skyrockets globally.

Bondada Engineering H1 Revenue Jumps 151%

Bondada Engineering Limited reports explosive H1 FY2025 growth with revenue surging 151% to ₹3,051 million and net profit climbing 114%, fueled by telecom and renewable energy expansion.

US Tariffs Crush Indian Exports: 37.5% Plunge

GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.

Mutual Fund AMCs: AUM Growth vs Shareholder Value

Indian mutual fund AMCs are caught in a paradox - record AUM growth isn't translating to shareholder returns. Discover why bigger isn't always better in the ₹50 lakh crore industry.

Governance Drives India's Next Unicorn Wave: BMU Report

A groundbreaking BMU Leadership Report 2025 highlights how strong governance frameworks, not just entrepreneurial hustle, will define India's future unicorn landscape. Discover the shifting priorities for startup success.

Page 1 of 4